Marina Amerali
Overview
Explore the profile of Marina Amerali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lagadinou M, Amerali M, Michailides C, Chondroleou A, Skintzi K, Spiliopoulou A, et al.
Pathogens
. 2025 Jan;
13(12.
PMID: 39770395
: The increased prevalence of antibiotic resistance among Gram-negative bacteria presents a severe public health challenge, leading to increased mortality rates, prolonged hospital stays, and higher medical costs. In Greece,...
2.
Lagadinou M, Antzoulas P, Eleftherakis G, Chatzigrigoriadis C, Amerali M, Michailides C, et al.
Infez Med
. 2024 Dec;
32(4):532-537.
PMID: 39660162
is a Gram-negative coccobacillus that is a part of normal oral flora of animals, especially cats and dogs. It is the most common causative agent for soft tissue infections following...
3.
Savulescu C, Prats-Uribe A, Brolin K, Makaric Z, Uuskula A, Panagiotakopoulos G, et al.
Vaccines (Basel)
. 2024 Nov;
12(11).
PMID: 39591197
European countries have included healthcare workers (HCWs) among priority groups for COVID-19 vaccination. We established a multi-country hospital network to measure the SARS-CoV-2 incidence and effectiveness of COVID-19 vaccines among...
4.
Lagadinou M, Markantes G, Amerali M, Mulita F, Marangos M, Michalaki M
Mater Sociomed
. 2024 Aug;
35(2):162-165.
PMID: 39102230
Background: Fever of unknown origin is quite common in everyday clinical practice, and the approach is challenging. Prolonged fever as the sole manifestation of craniopharyngioma has been rarely reported in...
5.
Rose A, Nicolay N, Sandonis Martin V, Mazagatos C, Petrovic G, Niessen F, et al.
Euro Surveill
. 2023 Nov;
28(47).
PMID: 37997666
IntroductionTwo large multicentre European hospital networks have estimated vaccine effectiveness (VE) against COVID-19 since 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in hospitalised severe acute respiratory illness (SARI) patients ...
6.
Rose A, Nicolay N, Sandonis Martin V, Mazagatos C, Petrovic G, Baruch J, et al.
Euro Surveill
. 2023 Nov;
28(47).
PMID: 37997665
IntroductionThe I-MOVE-COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine effectiveness (VE) in participating European countries since early 2021.AimWe aimed to measure VE against PCR-confirmed SARS-CoV-2 in patients ≥ ...
7.
Vasiliu A, Kohler N, Altpeter E, Agisdottir T, Amerali M, Arrazola de Onate W, et al.
Euro Surveill
. 2023 Oct;
28(42).
PMID: 37855907
BackgroundEuropean-specific policies for tuberculosis (TB) elimination require identification of key populations that benefit from TB screening.AimWe aimed to identify groups of foreign-born individuals residing in European countries that benefit most...
8.
Amerali M, Politou M
Eur J Clin Pharmacol
. 2022 Jul;
78(10):1555-1565.
PMID: 35871241
Purpose: Low molecular weight heparins (LMWHs) are a group of heterogenous moieties, long used in the prevention and treatment of thrombosis. They derive from heparin and since they are prepared...